Lupin launches generic Nystatin and Triamcinolone Acetonide Cream

November 30, 2018 | Friday | News

It is indicated for the treatment of cutaneous candidiasis

Pharma company Lupin has announced the launch of Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 %, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 % is the generic equivalent of Taro Pharmaceuticals' Nystatin and Triamcinolone Acetonide Cream.

It is indicated for the treatment of cutaneous candidiasis.

Nystatin and Triamcinolone Acetonide Cream had annual sales of $54.3 million in the US (IQVIA MAT September 2018).

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy